Tracks heart and lung changes over time using ultrasound and AI
Observes whether ultrasound and AI can spot worsening in adults with heart conditions.
Plain-language title generated from the registry record
Registry title: Multimodal Physiologic State Intelligence Study
Key facts
- Where
- New York, United StatesSee the site
Where in United States
- Truway Health, Inc.New York, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Truway Health, Inc.
- Trial code
- NCT07814118
- Record updated
- 10 September 2026
- Original description
The OMNIPHYS study will investigate whether multimodal ultrasound and other routinely collected clinical and physiologic data can be combined with artificial intelligence to characterize changes in a person's physiologic state over time. The study will examine cardiac, vascular, pulmonary, and systemic physiologic measurements and develop longitudinal models that describe baseline physiology, physiologic perturbation, compensation, deterioration, treatment response, and recovery. The study is observational and will not assign experimental treatments. The goal is to determine whether changes in multimodal physiologic patterns can be identified and characterized earlier and more reliably than conventional single-time-point assessment.Read full original descriptionShow less
OMNIPHYS: A Prospective Multimodal Longitudinal Study of AI-Enabled Physiologic State Modeling and Early Detection of Clinical Deterioration
The OMNIPHYS study will investigate whether multimodal ultrasound and other routinely collected clinical and physiologic data can be combined with artificial intelligence to characterize changes in a person's physiologic state over time. The study will examine cardiac, vascular, pulmonary, and systemic physiologic measurements and develop longitudinal models that describe baseline physiology, physiologic perturbation, compensation, deterioration, treatment response, and recovery. The study is observational and will not assign experimental treatments. The goal is to determine whether changes in multimodal physiologic patterns can be identified and characterized earlier and more reliably than conventional single-time-point assessment.
Inclusion: Adults aged 18 years or older who are capable of providing informed consent, or who meet applicable legally authorized representative requirements where permitted; Individuals undergoing routine clinical evaluation, diagnostic imaging, monitoring, treatment, or longitudinal follow-up, including individuals with relevant cardiovascular, vascular, pulmonary, renal, systemic, or other conditions represented within the OMNIPHYS research framework; Healthy volunteers without the conditions under study may participate as reference participants; Ability to undergo at least one protocol-relevant physiologic or imaging assessment and/or contribute eligible routinely collected clinical data; Availability of sufficient clinical, physiologic, imaging, or longitudinal outcome data for the applicable analysis; Willingness to permit collection and longitudinal analysis of protocol-defined research data in accordance with informed consent and applicable privacy and data-governance requirements.
Exclusion: Conditions or circumstances that, in the judgment of the responsible clinical investigator, make participation inappropriate or prevent meaningful longitudinal follow-up; Inability or unwillingness to provide informed consent or otherwise meet applicable consent requirements; Inability to obtain interpretable protocol-relevant physiologic or imaging data when such data are required for the applicable analysis; Withdrawal of consent or request for discontinuation of research participation where applicable; Any circumstance that would prevent collection, secure handling, or analysis of study data in accordance with the approved protocol and applicable requirements.